The orthopaedic surgery research team at Atrium Health Musculoskeletal Institute aims to address the opioid epidemic through objective and evidence-based clinical decision support in the outpatient and acute care setting. Our work, led by Rachel Seymour, PhD, and Joseph Hsu, MD, has been awarded several CDC-funded grants for this research. Our projects include:
For more information, contact Rachel Seymour.
Our goal with PRIMUM is to identify objective patient risk factors before prescribing opioids. PRIMUM is a clinical decision support tool that integrates with the electronic medical record (EMR) to promote safe controlled substance prescribing.
The PRIMUM logic monitors risk factors that may indicate misuse, abuse, or diversion of prescription opioids and benzodiazepines.
High-risk patients are identified by PRIMUM through alerts to prescribers. In response, the prescriber may continue or cancel the prescription.
In its first three years of use, PRIMUM identified one in four patients at risk for abuse and prevented nearly 43,000 high-risk prescriptions for controlled substances across Atrium Health. The alert influenced the prescribing decision in 1 in 5 encounters, and this result has been sustained for nearly four years. Learn more about how Atrium Health is addressing the opioid crisis in the Carolinas.
With additional funding from the CDC, our team enhanced PRIMUM by incorporating the CDC clinical practice guidelines within the EMR. These clinical decision support tools encourage prescribers to follow CDC recommendations when prescribing opioids for chronic pain.
We also built a controlled substance review component in the EMR that serves as a comprehensive toolkit for prescribers. The EMR now has all patient prescription history and risk information in one centralized location.
Other upgrades to PRIMUM include:
Much of the attention on the opioid crisis nationwide has focused on the outpatient setting, opioids prescribed for chronic pain, and patients who are already dependent on opioids. Addressing the need for a tool for the acute care setting and primary prevention, our team developed “Implementing a Multimodal Path to RecOVEry” (IMPROVE).
With IMPROVE, prescribers can manage pain while optimizing patient safety through safe opioid prescribing and increased use of multimodal pain management. Not only does it identify risk factors for opioid dependence, including alcohol use and mental health issues, the platform offers actionable guidance on a number of well-researched pain management strategies, from non-opioid medications to cryotherapy to cognitive therapy.
IMPROVE utilizes secure and authorized medical records to collect and provide information on risk factors for opioid dependence and overdose, including substance use and depression.
Through early identification of risk factors, the goals of this study include:
Professor and Vice Chair for Research
Susan Bear, PharmD - IMPROVE
Michael Beuhler, MD - PRIMUM
Michael Bosse, MD - PRIMUM
Michael Brennan, DDS - IMPROVE
Thomas Calabro, MSN - IMPROVE
Hope Carlson - IMPROVE
Manuel Castro, MD - IMPROVE
Lauren Cooper, MHA - IMPROVE
A. Britton Christmas, MD - IMPROVE
Susan L. Evans, MD - IMPROVE
Annette Fraley, MSN, RN - IMPROVE
Becky Fox, MSN, RN-BC - IMPROVE
Michael Gabriel, PharmD - IMPROVE
Michael Gibbs, MD - IMPROVE and PRIMUM
John Green, MD - IMPROVE
Christopher Griggs, MD - IMPROVE and PRIMUM
Marialice Gulledge, DNP, AG-ACNP, ANP - IMPROVE
Timothy C. Hetherington, MS - IMPROVE
Steven Jarrett, PharmD - IMPROVE and PRIMUM
Cynthia Lauer, MD - IMPROVE
Daniel Leas, MD - PRIMUM
Katherine Li, MD - IMPROVE
Randall R. McKnight, MD - IMPROVE
Andrew McWilliams, MD - IMPROVE
Stephanie Newby, MD - IMPROVE
Susan Odum, PhD - IMPROVE
James Rachal, MD - IMPROVE
Caroline Reinke, MD - IMPROVE
Tamar Roomian, MS, MPH - IMPROVE and PRIMUM
Michael Runyon, MD - IMPROVE and PRIMUM
Animita Saha, MD - IMPROVE and PRIMUM
D. Matthew Sullivan, MD - IMPROVE
Bradley Thomas, MD - IMPROVE
Brad Watling, MD - PRIMUM
Karon Wold, MSN - IMPROVE
Stephen Wyatt, DO - IMPROVE and PRIMUM
Ziqing Yu, MS - IMPROVE and PRIMUM
Learn more about our research on opioid safety, clinical decision support and pain management.
Joseph Hsu, MD, Rachel Seymour, PhD, and Meghan Wally, PhD, led a national taskforce to develop clinical practice guidelines for pain management for acute musculoskeletal pain. A panel of 15 members with expertise in orthopaedic trauma, pain management or both was convened to review the literature and develop recommendations on acute musculoskeletal pain management. The guideline was submitted to the Orthopaedic Trauma Association for review and was approved on October 16, 2018. This work is detailed in ‘Hsu et al. Clinical Practice Guidelines for Pain Management in Acute Musculoskeletal Injury. (2019). J Orthop Trauma, 33;5. E158-82.’ It was subsequently endorsed by the American Academy of Orthopaedic Surgeons and the American College of Surgeons.